Compounds > pargyline

pargyline and 7-nitroindazole

pargyline has been researched along with 7-nitroindazole in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bert, L; Denoroy, L; Desvignes, C; Lambás-Señas, L; Renaud, B; Vinet, L2
Araki, T; Imai, Y; Itoyama, Y; Kato, H; Kurosaki, R; Matsubara, M; Michimata, M; Mikami, T; Muramatsu, Y1
Araki, T; Imai, Y; Kurosaki, R; Matsubara, M; Michimata, M; Muramatsu, Y; Watanabe, H1

Other Studies

4 other study(ies) available for pargyline and 7-nitroindazole

ArticleYear
Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
    Neuroscience letters, 1999, Feb-19, Volume: 261, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, Micellar Electrokinetic Capillary; Dopamine; Enzyme Inhibitors; Extracellular Space; Indazoles; Male; Microdialysis; Monoamine Oxidase Inhibitors; Neostriatum; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pargyline; Rats; Rats, Sprague-Dawley

1999
Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
    Neuroscience letters, 1999, Apr-02, Volume: 264, Issue:1-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Electrophysiology; Enzyme Inhibitors; Extracellular Space; Indazoles; Male; Microdialysis; Monoamine Oxidase Inhibitors; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pargyline; Rats; Rats, Sprague-Dawley

1999
Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.
    Metabolic brain disease, 2002, Volume: 17, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Arginine; Brain Chemistry; Dopamine; Dopamine Agents; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Immunohistochemistry; Indazoles; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Neostriatum; Neurotoxicity Syndromes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pargyline; Tyrosine 3-Monooxygenase

2002
Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2004, Volume: 14, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Glial Fibrillary Acidic Protein; Immunohistochemistry; Indazoles; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Monoamine Oxidase Inhibitors; MPTP Poisoning; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pargyline; Parvalbumins; Protective Agents; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase

2004